MPN Advocates Network (MPN AN) operates for the benefit of MPN patients and acts independently of any other organization or company. The organisation is constituted as an independent steering committee within a parent organisation, the Leukaemia Patient Advocates Foundation, registered as a non-profit organisation in Switzerland. MPN AN has it’s own scientific advisory board.

Our Mission
The mission of the MPN Advocates Network is to enhance the ability of global patient advocacy organizations to improve:

  • Patient care
  • Quality of life
  • Patient empowerment

for all patients who have been diagnosed with myeloproliferative neoplasms (MPN) and their caregivers.

Our Vision
Our vision, quite simply, is a world without MPNs.

MPN AN receives support from a broad base of sponsors and diversified funding sources. Our funding for the activities comes from the variety of sources including pharmaceutical companies and philanthropy.

– Steering Committee –




Werner Zinkand
MPN-Netzwerk Germany
Felice Bombaci
Gruppo AIL Pazienti LMC, Italy


Viji Venkatesh
Friends of Max , India

Lyat Granati Espinosa
Max Foundation, Chile


Jon Mathias

MPN Voice, UK
Giora Sharf
LePaf Representative and Israeli Flute of Light
Patients Organization, Israel


Ken Young
MPN Alliance, Australia
Kapila Viges
MPN Research Foundation, USA

Dražen Vincek
Croatian Leukemia and Lymphoma Society (HULL), Croatia

– Management Team –  
Marija Stefkova